BIANCO, ROBERTO

BIANCO, ROBERTO  

Dipartimento di Medicina clinica e Chirurgia  

Mostra records
Risultati 1 - 20 di 151 (tempo di esecuzione: 0.02 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
A phase II study of beweekly oxaliplatin plus infusional 5fluorouracil and folinic acid (FOLFOX4) as first-line treatment of advenced gastric cancer patients 1.5 Abstract in rivista 2004 F., De Vita; M., Orditura; Matano, Elide; Bianco, Roberto; Carlomagno, Chiara; S., Infusino; Damiano, Vincenzo; E., Simeone; Mr, Diadema; E., Lieto; P., Castellano; S., Pepe; DE PLACIDO, Sabino; G., Galizia; F., Ciardiello; G., Catalano; Ar, Bianco
1599P - Effects of Hedgehog signaling inhibition on epithelial-stromal interactions in triple negative breast cancer cells 1.5 Abstract in rivista 2014 Servetto, A.; Raimondo, L.; Formisano, L.; Marciano, R.; Di Mauro, C.; Rosa, R.; D'Amato, V.; Veneziani, BIANCA MARIA; DE PLACIDO, Sabino; Bianco, Roberto
Quality of Life Analysis of TORCH, a Randomized Trial Testing First-Line Erlotinib Followed by Second-Line Cisplatin/Gemcitabine Chemotherapy in Advanced Non-Small-Cell Lung Cancer. 1.1 Articolo in rivista 2012 Di Maio, M.; Leighl, N. B.; Gallo, C.; Feld, R.; Ciardiello, F.; Butts, C.; Maione, P.; Gebbia, V.; Morgillo, F.; Wierzbicki, R.; Favaretto, A.; Alam, Y.; Cinieri, S.; Siena, S.; Bianco, Roberto; Riccardi, F.; Spatafora, M.; Ravaioli, A.; Felletti, R.; Fregoni, V.; Genestreti, G.; Rossi, A.; Mancuso, G.; Fasano, M.; Morabito, A.; Tsao, M. S.; Signoriello, S.; Perrone, F.; Gridelli, C.
Increased TGF-? as a Mechanism of Acquired Resistance to the Anti-EGFR Inhibitor Cetuximab through EGFR-MET Interaction and Activation of MET Signaling in Colon Cancer Cells 1.1 Articolo in rivista 2013 T., Troiani; E., Martinelli; S., Napolitano; D., Vitagliano; L. P., Ciuffreda; S., Costantino; F., Morgillo; A., Capasso; V., Sforza; A., Nappi; R., De Palma; E., D'Aiuto; L., Berrino; Bianco, Roberto; F., Ciardiello
Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis. 1.1 Articolo in rivista 2013 Damiano, Vincenzo; Rosa, Roberta; Formisano, Luigi; Nappi, Lucia; Gelardi, T.; Marciano, Roberta; Cozzolino, I.; Troncone, Giancarlo; Agrawal, S.; Veneziani, BIANCA MARIA; DE PLACIDO, Sabino; Bianco, Roberto; Tortora, G.
Antitumor activity of ZD6474, a small molecule VEGF receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to EGF receptor-targeted drugs. 1.5 Abstract in rivista 2003 Ciardiello, F; Bianco, Roberto; Caputo, R; Caputo, R; Damiano, V; Veneziani, BIANCA MARIA; De Vita, F; DE PLACIDO, Sabino; Bianco, Ar; Tortora, G.
INHIBITION OF CANCER CELL GROWTH AND INVASION BY TARGETING C-SRC IN BREAST CANCER MODELS RESISTANT TO ANTI-HER2 DRUGS 1.5 Abstract in rivista 2011 Formisano, L.; Damiano, V.; Nappi, L.; Rosa, R.; Gelardi, T.; D’Amato, C.; Marciano, R.; De Maio, A. P.; Ferrara, R.; Tortora, G.; Veneziani, BIANCA MARIA; DE PLACIDO, Sabino; Bianco, Roberto
Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa). 1.1 Articolo in rivista 2002 Cataldo, Bianco; Giampaolo, Tortora; Bianco, Roberto; Roberta, Caputo; Veneziani, BIANCA MARIA; Rosa, Caputo; Vincenzo, Damiano; Teresa, Troiani; Gabriella, Fontanini; David, Raben; Stefano, Pepe; A., Raffaele Bianco; Fortunato, Ciardiello
High-rsolution melting analysis (HRMA) for KRAS mutatiinal study in patients with metastatic colorectal cancer (mCRC pts) 1.5 Abstract in rivista 2012 De Stefano, A; Malapelle, Umberto; Carlomagno, Chiara; Bianco, Roberto; Marciano, Roberta; Cimminiello, C; Colantuoni, M; DE PLACIDO, Sabino; Troncone, Giancarlo
Targeting SRC tyrosine kinase to overcome resistance to HER-inhibitors in humancancer 8.07 Progetti di Ricerca Finanziati 2011 Bianco, Roberto
Mechanisms of resistance development against trastuzumab (Herceptin) in an in vivo breast cancer model. 1.1 Articolo in rivista 2004 Ritter, Ca; Bianco, Roberto; Dugger, T; Forbes, J; Qu, S; Rinehart, C; King, W; Arteaga, Cl
Addition of erlotinib to fluoropyrimidine-oxaliplatin-basedchemotherapy with or without bevacizumab: Two sequential phase I trials 1.1 Articolo in rivista 2011 Carlomagno, Chiara; Gennaro, Daniele*; Bianco, Roberto; Marciano, Roberta; Damiano, Vincenzo; Elide, Matano; Nappi, Lucia; Stefano, Pepe; DE PLACIDO, Sabino; Giampaolo, Tortora
A novel mdm2 antisense oligonucleotide has antitumor activity and potentiates cytotoxic drugs acting by different mechanisms in human colon cancer. 1.1 Articolo in rivista 2000 Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Chen, J; Agrawal, S; Bianco, Ar; Ciardiello, F.
Enzastaurin inhibits tumors sensitive and resistant to anti-EGFR drugs 1.1 Articolo in rivista 2008 Gelardi, Teresa; Caputo, R; Damiano, Vincenzo; Daniele, Gennaro; Pepe, Stefano; Ciardiello, F; Lahn, M; Bianco, Roberto; Tortora, Giampaolo
Combined blockade of PKA and bcl-2 by antisense strategy induces apoptosis and inhibits tumor growth and angiogenesis. 1.1 Articolo in rivista 2001 Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Fontanini, G; Cuccato, S; DE PLACIDO, Sabino; Bianco, Ar; Ciardiello, F.
VEGF Receptor 1 contributes to resistance to anti-EGFR drugs in human cancer cells. 1.1 Articolo in rivista 2008 Bianco, Roberto; Rosa, R; Damiano, V; Daniele, G; Gelardi, T; Garofalo, S; Tarallo, V; De Falco, S; Melisi, D; Benelli, R; Albini, A; Ryan, A; Ciardiello, F; Tortora, Giampaolo
Oral antisense targeting protein kinase A cooperates with taxol and inhibits tumor growth, angiogenesis and growth factors production. 1.1 Articolo in rivista 2000 Tortora, Giampaolo; Bianco, Roberto; Damiano, Vincenzo; Fontanini, G; DE PLACIDO, Sabino; Bianco, Ar; Ciardiello, F.
Zoledronic acid cooperates with a cyclooxygenase-2 inhibitor and gefitinib in inhibiting breast and prostate cancer. 1.1 Articolo in rivista 2005 Melisi, Davide; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Veneziani, BIANCA MARIA; Bianco, Ar; DE PLACIDO, Sabino; Ciardiello, F; Tortora, Giampaolo
Inhibition of mTOR pathway by everolimus cooperates with EGFR inhibitors in human tumors sensitive and resistant to anti-EGFR drugs 1.1 Articolo in rivista 2008 Bianco, Roberto; Garofalo, S; Rosa, R; Damiano, V; Gelardi, T; Daniele, G; Ciardiello, F; Tortora, Giampaolo
P0081 Src inhibitors act through different mechanisms to cooperate with EGFR or MEK inhibitors in NSCLC models sensitive or resistant to erlotinib 1.5 Abstract in rivista 2014 Raimondo, L.; Formisano, L.; Rosa, R.; D?amato, C.; D?amato, V.; Nappi, L.; Marciano, R.; Di Mauro, C.; Servetto, A.; Damiano, V.; Veneziani, BIANCA MARIA; DE PLACIDO, Sabino; Bianco, Roberto